 |
인쇄하기
취소
|
Health Insurance to cover Elaprase and Naglazyme
Those who have suffered from Mucopolysaccharidosis II (MPS II) and Mucopolysaccharidosis VI (MPS VI) will be covered by health insurance, the Ministry of Health, Welfare and Family Affairs said on December 22.
Elaprase is the first and only enzyme replacement therapy approved for people suffering from Hunter syndrome. The product, which is given as weekly infusions, replaces the missing or d...
Elaprase is the first and only enzyme replacement therapy approved for people suffering from Hunter syndrome. The product, which is given as weekly infusions, replaces the missing or d...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.